The United States contributed to the Epidermolysis Bullo's highest prevalent cases, accounting for ~65% of the 7MM in 2023.

GENEVA, SWITZERLAND / ACCESSWIRE / /RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the ...

The Food and Drug Administration (FDA) has accepted for review the resubmitted Biologics License Application (BLA) for prademagene zamikeracel for the treatment of recessive dystrophic epidermolysis ...

FDA accepts BLA resubmission of pz-cel in recessive dystrophic epidermolysis bullosa and sets PDUFA target action date of April 29, 2025Company ...

The Company's BLA for pz-cel was previously accepted for Priority Review by the FDA for patients with RDEB. Abeona may be ...

Irish actor Colin Farrell recently finished the Dublin Marathon in 4:06:45, and he ran the last 2.5 miles while pushing his ...

Abeona Therapeutics (ABEO) announced that the U.S. Food and Drug Administration, FDA, has accepted for review Abeona’s resubmission of ...

Graeme Souness has been made a CBE for his services to football and charity. The former Rangers and Liverpool star said ...

The Penguin star crossed the finish line in just over four hours with longtime friend Emma Fogarty, who has a rare genetic ...

Carol Schober-Flores, BSN, RN, is a Mohs Surgical Nurse and Epidermolysis Bullosa Nurse Specialist, University Hospital, Denver, CO. Topical ointments can be applied directly over the Mepitel ...